WST
West Pharmaceutical Services Inc
361.80$
-0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.1% | +3.3% | +20.0% | +9.6% | +27.2% | +28.7% | +23.6% | +24.0% | +7.3% | -15.9% | +15.5% | |
| – | -0.1% | +0.9% | +6.6% | +8.0% | -1.0% | +5.5% | +12.1% | -1.4% | +13.8% | +13.2% | +8.5% | |
| – | +59.1% | -34.1% | -17.4% | -6.2% | +61.6% | +39.3% | +10.3% | -36.8% | -1.7% | -19.7% | +27.3% | |
| – | – | -50.7% | +93.6% | -81.3% | +213.4% | -36.2% | -182.8% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +2,651.7% | |
| – | +17.4% | +29.3% | -23.1% | -20.0% | +20.7% | +38.0% | +45.3% | +12.3% | +27.2% | +4.1% | -24.2% | |
| – | +24.5% | +35.8% | -24.0% | -24.6% | +126.2% | -21.3% | +41.0% | +13.9% | +27.9% | +2.7% | -24.5% | |
| – | +11.3% | +10.5% | +9.2% | +7.7% | +7.1% | +6.7% | +6.2% | +5.9% | +5.4% | +3.7% | +3.6% | |
| – | +36.6% | +898.2% | +33.1% | -4.8% | +17.4% | +39.0% | +31.5% | +46.3% | +103.1% | +25.6% | -76.4% | |
| – | +22.9% | +154.7% | -50.0% | -99.7% | – | -103.8% | -4.3% | +1,968.2% | -94.7% | +1,050.0% | -96.0% | |
| – | +34.7% | +174.5% | -4.3% | -26.0% | -54.4% | +272.6% | +22.6% | +74.7% | +56.5% | +35.5% | -70.3% | |
| – | -23.7% | -471.0% | – | +208.5% | +0.2% | +73.5% | -16.6% | -10.5% | -130.7% | – | – | |
| – | +14.1% | -39.1% | +169.3% | +38.8% | +30.9% | +23.8% | +10.9% | +32.9% | -5.7% | -33.3% | +69.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.